New community program aims to improve diabetes care for vulnerable populations
NCT ID NCT05097534
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested a community-based program for people with type 2 diabetes. Participants received diabetes education, dietary counseling, physical and occupational therapy, and help with social needs like finances and mental health. The goal was to see if this approach could improve blood sugar control, weight, and blood pressure compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- community-based program including diabetes education, dietary counseling, physical and occupational therapy, and social needs support
- What this could lead to
- If successful, this approach could offer a practical model for improving diabetes control in vulnerable communities.
- What could go wrong
- This is a small, completed study with 98 participants, so results may not apply broadly. The program is complex and may be hard to replicate elsewhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
98 people
The number who actually took part.
- Started
-
Dec 2021
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 to 84 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients aged 13-84, and 2. Patients diagnosed with type 2 diabetes, and 3. Patients have a BMI equal to or \>25 (23, if Asians), and 4. Hemoglobin A1c value equal to or \>7% Exclusion Criteria: 1. Ages \<13 or \>84 2. Pregnancy. If a subject becomes pregnant, they will advised to discontinue the study. 3. Previous diagnosis of type 1 diabetes 4. Inability to participate for 12-month duration (e.g., Disorders that might compromise survival, planning to relocate outside the geographical coverage of University of Texas Medical Branch (UTMB) clinics 5. Other medical condition or medication administration deemed exclusionary by the study investigators 6. Prisoners
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Vincent House Clinic
Galveston, Texas, 77550, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can a vegan diet shield police officers from heart disease?
- Can a health coach in your patient portal help you lose weight?
- Common antibiotic may boost diabetes control
- Can continuous glucose monitors safely tighten hospital blood sugar control?